Kubota Pharmaceutical Holdings Co., Ltd. (4596)

Market cap
¥11.2B
P/E ratio
Kubota Pharmaceutical develops innovative eye disease treatments including wearable myopia devices and pharmaceuticals for conditions like diabetic retinopathy.
Period EndReturn on equity (%) (Million JPY)YoY (%)
Dec 31, 2025-42.2-36.07%
Dec 31, 2024-66+46.20%
Dec 31, 2023-45.2-9.22%
Dec 31, 2022-49.8-3.53%
Dec 31, 2021-51.6+48.86%
Dec 31, 2020-34.6-50.97%
Dec 31, 2019-70.7-93.45%
Dec 31, 2018-1,078.5+2480.86%
Dec 31, 2017-41.8-12.66%
Dec 31, 2016-47.8
AI Chat